脑力智宝治疗脑梗死后遗症的疗效观察  

Observation of Therapeutic Effects of Naolizhibao on Cerebral Infarction Sequel

作　　者：瞿泸 

机构地区：[1]宜良县红十字会医院,云南宜良652100

出　　处：《昆明医学院学报》2007年第02B期51-53,共3页Journal of Kunming Medical College

摘　　要：目的探讨脑力智宝(李氏5号方)治疗脑梗死后遗症患者的临床疗效.方法治疗前后采用中国修订韦氏智力量表简式手册检查,脑电图及头颅CT/MRI检查.分为脑力智宝+脑活素组及脑活素组,3个月为1疗程,治疗两个疗程后进行随访,判定疗效.结果应用脑力智宝胶囊组80例,显效44例,占55.1%;有效31例,占38.8%;无效5例,占6.1%,与对照组比较,经秩和检验P<0.05,差异有统计学意义.结论脑力智宝能明显改善脑梗死后遗症患者运动、语言及精神方面症状.本研究结果对于脑部疾病的治疗提供了一定的临床借鉴.Objective To report the therapeutic effects of Naolizhibao on 80 cases with cerebral infarction sequel and to explore its mechanisms. Methods Patients were divided into two groups： one with Naolizhibao and cerebrolysin, and one with cerebrolysin only. The two groups underwent the examination of Webster intelli-gence scale, electroencephalogram （EEG） and cranio CT/MRI. All patients were followed up after two courses of treatment and the therapeutic effects were evaluated. Results Naolizhibao was found with effect in 44 cases （55.1%）, and to be effective in 31 cases （38.8%）, and to be ineffective in 5 cases （6. 1% ）. There was sta-tistical difference between the groups （P 〈 0. 05）. Conclusion Naolizhibao has a positive effect on improving the symptoms of movement, language and mentality.The result of the research may be favorable to the treatment of cerebral diseases.

关 键 词：脑力智宝 脑梗死 后遗症 治疗 

分 类 号：R54[医药卫生—心血管疾病]